Login here to update your profile  
My Profile

Jeffrey Krischer, PHD

Administrative Appointment: Division Chief
Primary Department: COLLEGE OF MEDICINE PEDIATRICS

Distinguished Prof & Director
COLLEGE OF MEDICINE PEDIATRICS

Distinguished Professor
COLLEGE OF MEDICINE NEUROLOGY

profile Image
Contacts
Email: jkrische@health.usf.edu
Phone: (813) 396-9512
Office: HLM, 201
Mailing address 3650 Spectrum Blvd
Tampa, FL 33612
View My C.V.
 
Education
  • PHD, Applied Mathematics, Harvard University, Cambridge, United States - 1974.
  •  
     


    Selected Publications
  • Richesson RL, Andrews JE, Krischer JP. Use of SNOMED CT to represent clinical research data: a semantic characterization of data items on case report forms in vasculitis research. Journal of the American Medical Informatics Association : JAMIA. 13(5) : 536-46, .
  • Andrews JE, Richesson RL, Krischer J. Variation of SNOMED CT coding of clinical research concepts among coding experts. Journal of the American Medical Informatics Association : JAMIA. 14(4) : 497-506, .
  • Richesson RL, Krischer J. Data standards in clinical research: gaps, overlaps, challenges and future directions. Journal of the American Medical Informatics Association : JAMIA. 14(6) : 687-96, .
  • Roetzheim RG, Christman LK, Jacobsen PB, Cantor AB, Schroeder J, Abdulla R, Hunter S, Chirikos TN, Krischer JP. A randomized controlled trial to increase cancer screening among attendees of community health centers. Annals of family medicine. 2(4) : 294-300, .
  • Knowles MR, Ostrowski LE, Leigh MW, Sears PR, Davis SD, Wolf WE, Hazucha MJ, Carson JL, Olivier KN, Sagel SD, Rosenfeld M, Ferkol TW, Dell SD, Milla CE, Randell SH, Yin W, Sannuti A, Metjian HM, Noone PG, Noone PJ, Olson CA, Patrone MV, Dang H, Lee HS, Hurd TW, Gee HY, Otto EA, Halbritter J, Kohl S, Kircher M, Krischer J, Bamshad MJ, Nickerson DA, Hildebrandt F, Shendure J, Zariwala MA. Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. American journal of respiratory and critical care medicine. 189(6) : 707-17, 2014.
  • Pescovitz MD, Greenbaum CJ, Bundy B, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, Moran A, Raskin P, Rodriguez H, Schatz DA, Wherrett DK, Wilson DM, Krischer JP, Skyler JS. B-lymphocyte depletion with rituximab and β-cell function: two-year results. Diabetes care. 37(2) : 453-9, 2014.
  • Elding Larsson H, Vehik K, Gesualdo P, Akolkar B, Hagopian W, Krischer J, Lernmark Å, Rewers M, Simell O, She JX, Ziegler A, Haller MJ. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatric diabetes. 15(2) : 118-26, 2014.
  • Orban T, Bundy B, Becker DJ, Dimeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Peakman M, Raskin P, Russell WE, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS. Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment. Diabetes care. 37(4) : 1069-75, 2014.
  • Langford CA, Monach PA, Specks U, Seo P, Cuthbertson D, McAlear CA, Ytterberg SR, Hoffman GS, Krischer JP, Merkel PA. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's). Annals of the rheumatic diseases. 73(7) : 1376-9, 2014.
  • Hadley D, Cheung RK, Becker DJ, Girgis R, Palmer JP, Cuthbertson D, Krischer JP, Dosch HM. Large-scale prospective T cell function assays in shipped, unfrozen blood samples: experiences from the multicenter TRIGR trial. Clinical and vaccine immunology : CVI. 21(2) : 203-11, 2014.
  • Lee HS, Burkhardt BR, McLeod W, Smith S, Eberhard C, Lynch K, Hadley D, Rewers M, Simell O, She JX, Hagopian B, Lernmark A, Akolkar B, Ziegler AG, Krischer JP. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes/metabolism research and reviews. 30(5) : 424-34, 2014.
  • Sosenko JM, Skyler JS, Mahon J, Krischer JP, Greenbaum CJ, Rafkin LE, Beam CA, Boulware DC, Matheson D, Cuthbertson D, Herold KC, Eisenbarth G, Palmer JP. Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes. Diabetes care. 37(4) : 979-84, 2014.
  • Xu P, Qian X, Schatz DA, Cuthbertson D, Krischer JP. Distribution of C-peptide and its determinants in North American children at risk for type 1 diabetes. Diabetes care. 37(7) : 1959-65, 2014.
  • Batshaw ML, Groft SC, Krischer JP. Research into rare diseases of childhood. JAMA. 311(17) : 1729-30, 2014.
  • Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA. 311(22) : 2279-87, 2014.
  • Lin Y, Qian X, Krischer J, Vehik K, Lee HS, Huang S. A rule-based prognostic model for type 1 diabetes by identifying and synthesizing baseline profile patterns. PloS one. 9(6) : e91095, 2014.
  • Krischer JP. The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia. 56(9) : 1919-24, 2013.
  • Vehik K, Fiske SW, Logan CA, Agardh D, Cilio CM, Hagopian W, Simell O, Roivainen M, She JX, Briese T, Oikarinen S, Hyoty H, Ziegler AG, Rewers M, Lernmark A, Akolkar B, Krischer JP, Burkhardt BR. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes/metabolism research and reviews. 29(7) : 557-67, 2013.
  • Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Pickersgill L, de Koning E, Ziegler AG, Böehm B, Badenhoop K, Schloot N, Bak JF, Pozzilli P, Mauricio D, Donath MY, Castaño L, Wägner A, Lervang HH, Perrild H, Mandrup-Poulsen T. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet. 381(9881) : 1905-15, 2013.
  • Young L, Lee HS, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP, Goldberg HJ, Downey GP, Swigris JJ, Taveira-DaSilva AM, Krischer JP, Trapnell BC, McCormack FX. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. The Lancet. Respiratory medicine. 1(6) : 445-52, 2013.
  • Quenan S, Strueven V, Saxer N, Laffitte E, Kaya G, Krischer J, Hafezi F, Le Gal FA. Pruritic acquired nevus of Ota. Dermatology (Basel, Switzerland). 227(2) : 186-8, 2013.
  • Adl AA, Qian X, Xu P, Vehik K, Krischer JP. Feature ranking based on synergy networks to identify prognostic markers in DPT-1. EURASIP journal on bioinformatics & systems biology. 2013(1) : 12, 2013.
  • Leigh MW, Hazucha MJ, Chawla KK, Baker BR, Shapiro AJ, Brown DE, Lavange LM, Horton BJ, Qaqish B, Carson JL, Davis SD, Dell SD, Ferkol TW, Atkinson JJ, Olivier KN, Sagel SD, Rosenfeld M, Milla C, Lee HS, Krischer J, Zariwala MA, Knowles MR. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Annals of the American Thoracic Society. 10(6) : 574-81, 2013.
  • Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP. Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes. 62(12) : 4179-83, 2013.
  • Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes care. 36(9) : 2615-20, 2013.
  • Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo SH, Geschwind MD, Xia G, Mazzoni P, Krischer JP, Cuthbertson D, Holbert AR, Ferguson JH, Pulst SM, Subramony SH. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet journal of rare diseases. 8: 177, 2013.
  • Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Iklé D, Kallenberg CG, Krischer J, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Johnson KJ, Merkel PA. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Annals of the rheumatic diseases. 72(8) : 1342-50, 2013.
  • Akers AL, Ball KL, Clancy M, Comi AM, Faughnan ME, Gopal-Srivastava R, Jacobs TP, Kim H, Krischer J, Marchuk DA, McCulloch CE, Morrison L, Moses M, Moy CS, Pawlikowska L, Young WL. Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. The Journal of rare disorders. 1(1) : 5, 2013.
  • Lee HS, Briese T, Winkler C, Rewers M, Bonifacio E, Hyoty H, Pflueger M, Simell O, She JX, Hagopian W, Lernmark A, Akolkar B, Krischer JP, Ziegler AG. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia. 56(8) : 1705-11, 2013.
  • Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers MJ, Schatz DA, Krischer JP. Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth. Diabetes care. 35(9) : 1821-5, 2012.
  • Shurin S, Krischer J, Groft SC. Clinical trials In BMT: ensuring that rare diseases and rarer therapies are well done. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(1 Suppl) : S8-11, 2012.
  • Monach PA, Kümpers P, Lukasz A, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Carette S, Ding L, Hoffman GS, Iklé D, Kallenberg CG, Khalidi NA, Langford CA, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Haubitz M, Merkel PA. Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. PloS one. 7(1) : e30197, 2012.
  • Richesson RL, Sutphen R, Shereff D, Krischer JP. The Rare Diseases Clinical Research Network Contact Registry update: features and functionality. Contemporary clinical trials. 33(4) : 647-56, 2012.
  • Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP. The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes. Diabetes care. 35(7) : 1552-5, 2012.
  • Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M. Growth differences between North American and European children at risk for type 1 diabetes. Pediatric diabetes. 13(5) : 425-31, 2012.
  • Couluris M, Kinder BW, Xu P, Gross-King M, Krischer J, Panos RJ. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. Lung. 190(5) : 523-7, 2012.
  • Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes care. 35(10) : 1975-80, 2012.
  • Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes care. 35(6) : 1213-8, 2012.
  • Vehik K, Cuthbertson D, Ruhlig H, Schatz DA, Peakman M, Krischer JP. Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes care. 34(7) : 1585-90, 2011.
  • Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP. Development of autoantibodies in the TrialNet Natural History Study. Diabetes care. 34(9) : 1897-901, 2011.
  • Lee HS, Paik MC, Rundek T, Sacco RL, Dong C, Krischer JP. Heritability Estimation using Regression Models for Correlation. Journal of biometrics & biostatistics. 2(119) : , 2011.
  • Vehik K, Haller MJ, Beam CA, Schatz DA, Wherrett DK, Sosenko JM, Krischer JP. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. Diabetes care. 34(2) : 358-62, 2011.
  • Richesson RL, Smith SB, Malloy J, Krischer JP. Achieving standardized medication data in clinical research studies: two approaches and applications for implementing RxNorm. Journal of medical systems. 34(4) : 651-7, 2010.
  • Sosenko JM, Mahon J, Rafkin L, Lachin JM, Krause-Steinrauf H, Krischer JP, Cuthbertson D, Palmer JP, Thompson C, Greenbaum CJ, Skyler JS. A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Pediatric diabetes. : , 2010.
  • Sosenko JM, Palmer JP, Rafkin LE, Krischer JP, Cuthbertson D, Greenbaum CJ, Eisenbarth G, Skyler JS. Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes care. 33(3) : 620-5, 2010.
  • Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ishii H, Yokoba M, Tanaka N, Yamaguchi E, Eda R, Tsuchihashi Y, Morimoto K, Akira M, Terada M, Otsuka J, Ebina M, Kaneko C, Nukiwa T, Krischer JP, Akazawa K, Nakata K. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. American journal of respiratory and critical care medicine. 181(12) : 1345-54, 2010.
  • Bonifacio E, Yu L, Williams AK, Eisenbarth GS, Bingley PJ, Marcovina SM, Adler K, Ziegler AG, Mueller PW, Schatz DA, Krischer JP, Steffes MW, Akolkar B. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. The Journal of clinical endocrinology and metabolism. 95(7) : 3360-7, 2010.
  • Levis S, Strickman-Stein N, Doerge DR, Krischer J. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women. Contemporary clinical trials. 31(4) : 293-302, 2010.
  • Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D, Krischer JP, Sosenko JM, Skyler JS. Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes care. 33(12) : 2508-13, 2010.
  • Seminara J, Tuchman M, Krivitzky L, Krischer J, Lee HS, Lemons C, Baumgartner M, Cederbaum S, Diaz GA, Feigenbaum A, Gallagher RC, Harding CO, Kerr DS, Lanpher B, Lee B, Lichter-Konecki U, McCandless SE, Merritt JL, Oster-Granite ML, Seashore MR, Stricker T, Summar M, Waisbren S, Yudkoff M, Batshaw ML. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Molecular genetics and metabolism. 100 Suppl 1: S97-105, 2010.
  • Sorkio S, Cuthbertson D, Bärlund S, Reunanen A, Nucci AM, Berseth CL, Koski K, Ormisson A, Savilahti E, Uusitalo U, Ludvigsson J, Becker DJ, Dupré J, Krischer JP, Knip M, Akerblom HK, Virtanen SM. Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial. Diabetes/metabolism research and reviews. 26(3) : 206-11, 2010.
  • Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz D, Eisenbarth G. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes care. 32(12) : 2269-74, 2009.
  • Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. Diabetes care. 32(9) : 1603-7, 2009.
  • Roesch LF, Casella G, Simell O, Krischer J, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW. Influence of fecal sample storage on bacterial community diversity. The open microbiology journal. 3: 40-6, 2009.
  • Richesson RL, Lee HS, Cuthbertson D, Lloyd J, Young K, Krischer JP. An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants. Contemporary clinical trials. 30(1) : 55-62, 2009.
  • Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC. Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individuals. Blood. : , 2008.
  • Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS. Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes care. 31(11) : 2188-92, 2008.
  • Moyers S, Richesson R, Krischer J. Trans-atlantic data harmonization in the classification of medicines and dietary supplements: a challenge for epidemiologic study and clinical research. International journal of medical informatics. 77(1) : 58-67, 2008.
  • Andrews JE, Patrick TB, Richesson RL, Brown H, Krischer JP. Comparing heterogeneous SNOMED CT coding of clinical research concepts by examining normalized expressions. Journal of biomedical informatics. 41(6) : 1062-9, 2008.
  • Richesson RL, Fung KW, Krischer JP. Heterogeneous but "standard" coding systems for adverse events: Issues in achieving interoperability between apples and oranges. Contemporary clinical trials. 29(5) : 635-45, 2008.
  • Kumar NB, Besterman-Dahan K, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Krischer JP. Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. Clinical medicine. Urology [electronic resource]. 1: 1-14, 2008.
  • Richesson RL, Malloy JF, Paulus K, Cuthbertson D, Krischer JP. An automated standardized system for managing adverse events in clinical research networks. Drug safety : an international journal of medical toxicology and drug experience. 31(10) : 807-22, 2008.
  • Couluris M, Mayer JL, Freyer DR, Sandler E, Xu P, Krischer JP. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. Journal of pediatric hematology/oncology. 30(11) : 791-7, 2008.
  • Krischer MM, Xu P. Determinants of psychological functioning in patients undergoing radiotherapy: a descriptive study. Journal of psychosocial oncology. 26(4) : 1-13, 2008.
  • Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. American journal of respiratory and critical care medicine. 177(7) : 752-62, 2008.
  • Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes care. 30(9) : 2314-20, 2007.
  • Krischer MM, Xu P, Meade CD, Jacobsen PB. Self-administered stress management training in patients undergoing radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(29) : 4657-62, 2007.
  • Richesson R, Syed A, Guillette H, Tuttle MS, Krischer J. A web-based SNOMED CT browser: distributed and real-time use of SNOMED CT during the clinical research process. Studies in health technology and informatics. 129(Pt 1) : 631-5, 2007.
  • Richesson RL, Young K, Lloyd J, Adams T, Guillette H, Malloy J, Krischer JP. An automated communication system in a Contact Registry for persons with rare diseases: tools for retaining potential clinical research participants. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. : 1094, 2007.
  • Richesson R, Young K, Guillette H, Tuttle M, Abbondondolo M, Krischer J. Standard terminology on demand: facilitating distributed and real-time use of SNOMED CT during the clinical research process. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. : 1076, 2006.
  • Krischer JP, Cuthbertson DD, Greenbaum C. Male sex increases the risk of autoimmunity but not type 1 diabetes. Diabetes care. 27(8) : 1985-90, 2004.
  • Fink E, Kokku PK, Nikiforou S, Hall LO, Goldgof DB, Krischer JP. Selection of patients for clinical trials: an interactive web-based system. Artificial intelligence in medicine. 31(3) : 241-54, 2004.
  • Krischer J. The biostatistics of prediction. Autoimmunity. 37(4) : 261-3, 2004.
  • Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC, LaPolla JP, Arango H, Hoffman MS, Martino M, Wakeley K, Griffin D, Blanco RW, Cantor AB, Xiao YJ, Krischer JP. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 13(7) : 1185-91, 2004.
  • Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. The Journal of clinical endocrinology and metabolism. 88(1) : 103-8, 2003.
  • Chirikos TN, Ruckdeschel JC, Krischer JP. Impact of clinical trials on the cost of cancer care. Medical care. 39(4) : 373-83, 2001.
  • Roetzheim RG, Pal N, van Durme DJ, Wathington D, Ferrante JM, Gonzalez EC, Krischer JP. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. Journal of the American Academy of Dermatology. 43(2 Pt 1) : 211-8, 2000.
  • Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. American journal of public health. 90(11) : 1746-54, 2000.
  • Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 89(11) : 2202-13, 2000.
  • Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP. Effects of health insurance and race on early detection of cancer. Journal of the National Cancer Institute. 91(16) : 1409-15, 1999.
  • Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Ayanian JZ, Krischer JP. The effects of physician supply on the early detection of colorectal cancer. The Journal of family practice. 48(11) : 850-8, 1999.
  • Cantor AB, Krischer JP, Cuthbertson DD, Schatz DA, Riley WJ, Malone J, Schwartz S, Quattrin T, Maclaren NK. Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. The Journal of clinical endocrinology and metabolism. 80(12) : 3739-43, 1995.
  • Papaconstantinou C, Krischer JP. An automated patient registration and treatment randomization system. Journal of medical systems. 19(6) : 445-56, 1995.

  • Profile last modified on 06/06/2015